Published in Cell Tissue Kinet on January 01, 1973
Cartilage ultrastructure after high pressure freezing, freeze substitution, and low temperature embedding. I. Chondrocyte ultrastructure--implications for the theories of mineralization and vascular invasion. J Cell Biol (1984) 1.06
Cell proliferation in colonic mucosa and carcinoma of the colon. Proc R Soc Med (1973) 0.83
Using Fractal Geometry and Universal Growth Curves as Diagnostics for Comparing Tumor Vasculature and Metabolic Rate With Healthy Tissue and for Predicting Responses to Drug Therapies. Discrete Continuous Dyn Syst Ser B (2013) 0.77
Effects of hypoxia on the kinetic and morphological characteristics of human melanoma cells grown as colonies in semi-solid agar medium. Br J Exp Pathol (1984) 0.75
Letter: Breast cancer regression under oestrogen therapy. Br Med J (1973) 0.75
Biochemical monitoring of cancer. A review. Ann Clin Biochem (1976) 1.83
Evaluation of dimethylhydrazine induced tumours in mice as a model system for colorectal cancer. Br J Cancer (1973) 1.83
Alpha-1-microglobulin: an indicator protein for renal tubular function. J Clin Pathol (1983) 1.80
Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J (1974) 1.69
Renal proximal dysfunction in patients with rheumatic diseases. Br Med J (Clin Res Ed) (1984) 1.57
TNM classification of genitourinary tumours 1987--position of the EORTC Genitourinary Group. Br J Urol (1988) 1.55
Sodium dodecyl sulphate polyacrylamide gel electrophoresis patterns of proteinuria in various renal diseases of childhood. Pediatr Nephrol (1991) 1.47
Quantitation of the response of lymphocytes in culture to specific and non-specific stimulation. Int Arch Allergy Appl Immunol (1967) 1.44
[Degradation of thymidine by transformed lymphocytes]. Rev Fr Etud Clin Biol (1965) 1.43
Analyses of DNA content, nuclear size and cell proliferation of transitional cell carcinoma in man. Cancer (1969) 1.41
Proliferation and ultrastructure of papillary transitional cell carcinoma of the human bladder. Cancer (1971) 1.41
Immunologically stimulated human peripheral blood lymphocytes in vitro. I. Morphological changes. Int Arch Allergy Appl Immunol (1966) 1.37
C reactive protein: an aid to assessment and monitoring of acute pancreatitis. J Clin Pathol (1984) 1.34
Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas: findings in a multicenter study and experience in selected patients. Cancer (1980) 1.31
Cancer of the urinary tract. Adv Cancer Res (1970) 1.28
Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer. Br J Cancer (1985) 1.25
Cell proliferation in Burkitt tumours. Eur J Cancer (1966) 1.25
Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease. J Clin Pathol (1983) 1.25
Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes. Br J Cancer (1977) 1.24
Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis. Br J Surg (1985) 1.23
Cell death in normal and malignant tissues. Adv Cancer Res (1975) 1.22
Serum beta 2-microglobulin and C reactive protein concentrations in viral infections. J Clin Pathol (1984) 1.22
Relation of alpha 2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis. Am J Surg (1984) 1.20
The prognostic influence of serum neuron specific enolase in small cell lung cancer. Br J Cancer (1988) 1.18
Tubular dysfunction and microalbuminuria in insulin dependent diabetes. Arch Dis Child (1988) 1.16
The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. Br J Cancer (1993) 1.15
Results of the MRC myelomatosis trials for patients entered since 1980. Hematol Oncol (1988) 1.15
The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis. Br J Cancer (1985) 1.15
Proliferation characteristics of the various classes of cells in Hodgkin's disease. Cancer (1969) 1.14
CEA and tumor markers. Semin Oncol (1976) 1.13
Acute phase reactant proteins in cancer. Adv Cancer Res (1979) 1.12
Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer. Eur J Cancer Clin Oncol (1989) 1.10
Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring. Br J Cancer (1980) 1.08
Proximal renal tubular function in myelomatosis: observations in the fourth Medical Research Council trial. J Clin Pathol (1984) 1.07
Proliferative activity of leukaemic cells at various stages of acute leukaemia of childhood. Br J Haematol (1968) 1.04
The thoracic duct lymph in Hodgkin's disease. II. Quantitative analysis of the cellular composition of the lymph. Int J Cancer (1971) 1.02
Alpha-globulins in the surveillance of colorectal cancer. Biomedicine (1976) 1.01
Lymphocyte infiltration in bladder carcinoma. Rev Eur Etud Clin Biol (1970) 1.01
Cell proliferation in human malignant lymphomas. Analysis of labelling index and DNA content in cell populations obtained by biopsy. Eur J Cancer (1968) 1.00
Serum beta 2-microglobulin and human immunodeficiency virus infection. AIDS (1987) 0.99
Chromosome constitution of transitional cell carcinoma of the urinary bladder. Cancer (1972) 0.99
Blood muramidase activity in colorectal cancer. Br Med J (1974) 0.97
Serum hyaluronate as a marker of hepatic derangement in acute liver damage. J Hepatol (1991) 0.97
DNA synthesis and DNA content of leucocytes in acute leukaemia. Nature (1967) 0.97
Disorganization of mouse bladder epithelium induced by 2-acetylaminofluorene and 4-ethylsulfonylnaphthalene-1-sulfonamide. J Natl Cancer Inst (1971) 0.96
The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. Br J Cancer (1994) 0.95
Long-term prognostic value of serum beta 2 microglobulin in myelomatosis. Br J Haematol (1990) 0.95
DNA metabolism of the immunoglobulin-containing cells in the lymph nodes of rats. J Reticuloendothel Soc (1965) 0.95
Beta-2-microglobulin review: its relevance in clinical oncology. Med Pediatr Oncol (1980) 0.94
Combination of carcinoembryonic antigen and gamma glutamyl transpeptidase in the study of the evolution of colorectal cancer. Br J Cancer (1974) 0.94
Acute phase reactant proteins in prostatic cancer. Br J Urol (1977) 0.93
The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma. Cancer (1978) 0.93
The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer. Br J Cancer (1975) 0.93
Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer. Br J Cancer (1983) 0.92
The evolution of tumour cell populations in human bladder cancer. Br J Urol (1969) 0.92
Plasma protein profiles and prognosis in gastric cancer. Br J Cancer (1982) 0.92
Multivariate biochemical indicators of breast cancer: an evaluation of their potential in routine practice. Eur J Cancer (1978) 0.91
Prognostic significance of serum proteins in invasive bladder cancer. A preliminary report of the E.O.R.T.C. Urological Group. Eur J Cancer (1981) 0.91
Accumulation of calcium in the intramitochondrial dense bodies in mice. Exp Cell Res (1972) 0.91
Neuron-specific enolase as a guide to the treatment of small cell lung cancer. Eur J Cancer Clin Oncol (1987) 0.90
Activity of JM9 in advanced ovarian cancer: a phase I-II trial. Cancer Treat Rep (1985) 0.90
Repair of rat urinary bladder epithelium following injury by cyclophosphamide. Invest Urol (1970) 0.89
Proliferative potential of out-of-cycle leukaemic cells. Nature (1969) 0.89
The amylase-to-creatinine clearance ratio--a non-specific response to acute illness? Br J Surg (1982) 0.89
Hyaluronic acid in the assessment of liver graft function. Transplant Proc (1990) 0.89
The use of concanavalin A crossed immuno-affinoelectrophoresis to detect hormone-associated variations in alpha 1-acid glycoprotein. Clin Chim Acta (1981) 0.89
Disturbed proliferation of erythropoietic cells in pernicious anemia. Nature (1967) 0.88
Application of monoclonal antibodies to purified CEA in clinical radioimmunoassay of human serum. Br J Cancer (1981) 0.88
Isoelectric points of urinary light chains in myelomatosis: analysis in relation to nephrotoxicity. J Clin Pathol (1986) 0.88
Urinary protein profiles after burn injury. Burns Incl Therm Inj (1983) 0.88
Behaviour of serum beta 2-microglobulin and acute phase reactant proteins in chronic lymphocytic leukaemia. A multicentre study. Acta Haematol (1980) 0.87
Acute phase reactant proteins as aids to monitoring disease. Invest Cell Pathol (1980) 0.86
Serum prealbumin, retinol-binding protein, transferrin, and albumin levels in patients with large bowel cancer. J Natl Cancer Inst (1978) 0.86
Bone alkaline phosphatase in rheumatoid arthritis: a longitudinal study. J Rheumatol (1996) 0.86
The tumour marker CA 195 in colorectal and pancreatic cancer. Int J Biol Markers (1992) 0.86
Identification and measurement of paraprotein polymers by high performance gel filtration chromatography. Biomed Pharmacother (1985) 0.86
Transmissible venereal sarcoma of dogs. A histochemical and chromosomal analysis of tumours in Uganda. Rev Eur Etud Clin Biol (1970) 0.86
Serum beta 2-microglobulin in malignant and benign diseases of the stomach and pancreas. Biomedicine (1981) 0.85
Arrest of cell proliferation and protein synthesis in megaloblasts of pernicious anaemia. Acta Haematol (1969) 0.85
Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC). Br J Cancer (1992) 0.84
Clinical evaluation of serum tissue polypeptide-specific antigen (TPS) in non-small cell lung cancer. Eur J Cancer (1994) 0.84
Deoxyribonucleic acid content of antibody-containing cells in the rat lymph node. Nature (1965) 0.84
Serum beta-2-microglobulin in disorders of myeloid proliferation. Acta Haematol (1983) 0.83
The role of serum tumour markers to aid the selection of lung cancer patients for surgery and the assessment of prognosis. Eur J Cancer Clin Oncol (1985) 0.83
Acute phase reactant proteins in the clinical management of carcinoma of the bladder. Br J Urol (1979) 0.83
Cell proliferation in colonic mucosa and carcinoma of the colon. Proc R Soc Med (1973) 0.83
The proliferation of infectious mononucleosis lymphocytes in vitro. Acta Haematol (1967) 0.83
An evaluation of serum protein profiles in the long-term surveillance of prostatic cancer. Scand J Urol Nephrol (1980) 0.83
Inhibitory action of hydroxyurea on nucleic acid synthesis in cultures of human lymphocytes stimulated by pokeweed mitogen. Biochem Pharmacol (1968) 0.83
Commercial assays for serum osteocalcin give clinically discordant results. Clin Chem (1994) 0.82
Cell proliferation in Hodgkin's disease. Natl Cancer Inst Monogr (1973) 0.82
Analysis of proteinuria using a commercial system for automated electrophoresis and isoelectric focusing. Ann Clin Biochem (1988) 0.82
Plasma beta-2-microglobulin and fibronectin levels in beta-thalassaemia. Acta Haematol (1984) 0.82
Contribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancer. Eur Urol (1988) 0.82
Urinary protein isolation by high-performance ion-exchange chromatography. J Chromatogr (1983) 0.82
Purification and partial amino acid sequence of human urine protein 1. Evidence for homology with rabbit uteroglobin. J Chromatogr (1988) 0.82
The prognostic value of the tumour markers CA 195 and CEA in patients with adenocarcinoma of the pancreas. Eur J Surg Oncol (1992) 0.81
The recovery of mouse bladder epithelium after injury by 4-ethylsulphonylnaphthalene-1-sulphonamide. J Pathol (1972) 0.81
The total-time hypothesis in verbal learning. Psychol Bull (1967) 0.81